Trial · NCT01353313
Results by group142
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 142
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Survival Without Moderate/Severe Physiologic Bronchopulmonary Dysplasia (BPD) | Hydrocortisone | Moderate/severe BPD or death | 332 | Participants | |
| Survival Without Moderate/Severe Physiologic Bronchopulmonary Dysplasia (BPD) | Placebo | Moderate/severe BPD or death | 349 | Participants | |
| Survival Without Moderate/Severe Physiologic Bronchopulmonary Dysplasia (BPD) | Hydrocortisone | Survival without moderate/severe physiologic bronchopulmonary dysplasia (BPD) | 66 | Participants | |
| Survival Without Moderate/Severe Physiologic Bronchopulmonary Dysplasia (BPD) | Placebo | Survival without moderate/severe physiologic bronchopulmonary dysplasia (BPD) | 53 | Participants | |
| Survival Without Moderate/Severe Neurodevelopmental Impairment (NDI) | Hydrocortisone | Moderate/severe NDI or death | 226 | Participants | |
| Survival Without Moderate/Severe Neurodevelopmental Impairment (NDI) | Placebo | Moderate/severe NDI or death | 226 | Participants | |
| Survival Without Moderate/Severe Neurodevelopmental Impairment (NDI) | Hydrocortisone | Survival without moderate/severe neurodevelopmental impairment (NDI) | 132 | Participants | |
| Survival Without Moderate/Severe Neurodevelopmental Impairment (NDI) | Placebo | Survival without moderate/severe neurodevelopmental impairment (NDI) | 134 | Participants | |
| Number of Participants With Successful Extubation | Hydrocortisone | Successful extubation | 178 | Participants | |
| Number of Participants With Successful Extubation | Placebo | Successful extubation | 135 | Participants | |
| Number of Participants With Successful Extubation | Hydrocortisone | Unsuccessful or no extubation | 220 | Participants | |
| Number of Participants With Successful Extubation | Placebo | Unsuccessful or no extubation | 267 | Participants | |
| Total Deaths Before Discharge | Hydrocortisone | Death before discharge | 35 | Participants | |
| Total Deaths Before Discharge | Placebo | Death before discharge | 40 | Participants | |
| Total Deaths Before Discharge | Hydrocortisone | Survival to discharge | 363 | Participants | |
| Total Deaths Before Discharge | Placebo | Survival to discharge | 362 | Participants | |
| Number of Participants With Bronchopulmonary Dysplasia (BPD) Grade at 36 Weeks Postmenstrual Age | Hydrocortisone | Invasive PPV | 63 | Participants | |
| Number of Participants With Bronchopulmonary Dysplasia (BPD) Grade at 36 Weeks Postmenstrual Age | Placebo | Invasive PPV | 51 | Participants | |
| Number of Participants With Bronchopulmonary Dysplasia (BPD) Grade at 36 Weeks Postmenstrual Age | Hydrocortisone | NC O2 greater than 2L or CPAP/NIPPV | 152 | Participants | |
| Number of Participants With Bronchopulmonary Dysplasia (BPD) Grade at 36 Weeks Postmenstrual Age | Placebo | NC O2 greater than 2L or CPAP/NIPPV | 159 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01353313/results